Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility

Experimental Eye Research

Volumn 120, Issue , 2014, Pages 28-35

  Dismuke, W Michael ^a   Liang, Jin ^b   Overby, Darryl R ^c   Stamer, W Daniel ^a,b  

^a DUKE UNIVERSITY   (United States)

^b Duke University   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Aqueous humor; Conventional outflow; Glaucoma; Schlemm's canal

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP DERIVATIVE; ENDOTHELIN 1; GUANYLATE CYCLASE; MYOSIN LIGHT CHAIN; NITRIC OXIDE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; DIETHYLENETRIAMINE; NITRIC OXIDE DONOR; SODIUM NITROPRUSSIDE DEHYDRATE; UNCLASSIFIED DRUG;

AQUEOUS HUMOR; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DONOR; HUMAN; HUMAN CELL; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE CONTRACTILITY; TRABECULAR MESHWORK; VASCULAR SMOOTH MUSCLE; ASSAY; CELL CONTRACTILITY; CELL CONTRACTION ASSAY; CELL FUNCTION; EFFECTIVE CONCENTRATION; ENZYME ACTIVATION; MUSCLE CONTRACTILITY; MYOSIN LIGHT CHAIN PHOSPHORYLATION ASSAY; WESTERN BLOTTING;

AQUEOUS HUMOR; CONVENTIONAL OUTFLOW; GLAUCOMA; SCHLEMM'S CANAL;

ADULT; CELL PHYSIOLOGICAL PROCESSES; CELLS, CULTURED; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENZYME INHIBITORS; GUANYLATE CYCLASE; HUMANS; INFANT; MIDDLE AGED; MYOSIN LIGHT CHAINS; NITRIC OXIDE DONORS; NITROPRUSSIDE; OXADIAZOLES; PHOSPHORYLATION; QUINOXALINES; TISSUE DONORS; TRABECULAR MESHWORK; TRIAZENES;

EID: 84892870747     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.12.012     Document Type: Article

References (76)

1. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am. J. Ophthalmol. 2000, 130:429-440.
2. Bourke J.E., Li X., Foster S.R., Wee E., Dagher H., Ziogas J., Harris T., Bonacci J.V., Stewart A.G. Collagen remodelling by airway smooth muscle is resistant to steroids and beta(2)-agonists. Eur. Respir. J. 2011, 37:173-182.
3. Braughler J.M., Mittal C.K., Murad F. Purification of soluble guanylate cyclase from rat liver. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:219-222.
4. Calabrese E.J. Nitric oxide: biphasic dose responses. Crit. Rev. Toxicol. 2001, 31:489-501.
5. Cellini M., Versura P., Zamparini E., Bendo E., Campos E.C. Effects of endothelin-1 and flunarizine on human trabecular meshwork cell contraction. Exp. Biol. Med. 2006, 231:1081-1084.
6. Cheng C., van Haperen R., de Waard M., van Damme L.C., Tempel D., Hanemaaijer L., van Cappellen G.W., Bos J., Slager C.J., Duncker D.J., van der Steen A.F., de Crom R., Krams R. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel invivo technique. Blood 2005, 106:3691-3698.
7. Choritz L., Rosenthal R., Fromm M., Foerster M.H., Thieme H. Pharmacological and functional characterization of endothelin receptors in bovine trabecular meshwork and ciliary muscle. Ophthalmic Res. 2005, 37:179-187.
8. Civan M.M., Macknight A.D. The ins and outs of aqueous humour secretion. Exp. Eye Res. 2004, 78:625-631.
9. Dallot E., Pouchelet M., Gouhier N., Cabrol D., Ferre F., Breuiller-Fouche M. Contraction of cultured human uterine smooth muscle cells after stimulation with endothelin-1. Biol. Reprod. 2003, 68:937-942.
10. Defawe O.D., Kim S., Chen L., Huang D., Kenagy R.D., Renne T., Walter U., Daum G., Clowes A.W. VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen. J.Cell. Physiol. 2010, 222:230-237.
11. Dismuke W.M., Ellis D.Z. Activation of the BK(Ca) channel increases outflow facility and decreases trabecular meshwork cell volume. J.Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 2009, 25:309-314.
12. Dismuke W.M., Mbadugha C.C., Ellis D.Z. NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel. Am. J. Physiol. Cell Physiol. 2008, 294:C1378-C1386.
13. Draijer R., Atsma D.E., van der Laarse A., van Hinsbergh V.W. cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ. Res. 1995, 76:199-208.
14. Eglen R.M., Michel A.D., Sharif N.A., Swank S.R., Whiting R.L. The pharmacological properties of the peptide, endothelin. Br. J. Pharmacol. 1989, 97:1297-1307.
15. Ellis D.Z., Dismuke W.M., Chokshi B.M. Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 2009, 50:1808-1813.
16. Fernandez-Durango R., Rollin R., Mediero A., Roldan-Pallares M., Garcia Feijo J., Garcia Sanchez J., Fernandez-Cruz A., Ripodas A. Localization of endothelin-1 mRNA expression and immunoreactivity in the anterior segment of human eye: expression of ETA and ETB receptors. Mol. Vis. 2003, 9:103-109.
17. Filep J.G., Sirois M.G., Foldes-Filep E., Rousseau A., Plante G.E., Fournier A., Yano M., Sirois P. Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors. Br. J. Pharmacol. 1993, 109:880-886.
18. Filep J.G., Sirois M.G., Rousseau A., Fournier A., Sirois P. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br. J. Pharmacol. 1991, 104:797-804.
19. Grant W.M. Clinical tonography. Trans. Am. Acad. Ophthalmol. Oto-laryngol. 1951, 55:774-781.
20. Gruetter C.A., Gruetter D.Y., Lyon J.E., Kadowitz P.J., Ignarro L.J. Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J.Pharmacol. Exp. Ther. 1981, 219:181-186.
21. Heyne G.W., Kiland J.A., Kaufman P.L., Gabelt B.T. Effect of nitric oxide on anterior segment physiology in monkeys. Investig. Ophthalmol. Vis. Sci. 2013, 54:5103-5110.
22. Holland M., Langton P.D., Standen N.B., Boyle J.P. Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle. Br. J. Pharmacol. 1996, 117:119-129.
23. Ignarro L.J. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension 1990, 16:477-483.
24. Kallberg M.E., Brooks D.E., Garcia-Sanchez G.A., Komaromy A.M., Szabo N.J., Tian L. Endothelin 1 levels in the aqueous humor of dogs with glaucoma. J.Glaucoma 2002, 11:105-109.
25. Kallberg M.E., Brooks D.E., Gelatt K.N., Garcia-Sanchez G.A., Szabo N.J., Lambrou G.N. Endothelin-1, nitric oxide, and glutamate in the normal and glaucomatous dog eye. Vet. Ophthalmol. 2007, 10(Suppl.1):46-52.
26. Kimura M., White R.P., Wolf E.W., Robertson J.T. Responses of human basilar and other isolated arteries to novel nitric oxide donors. J.Cardiovasc. Pharmacol. 1998, 32:695-701.
27. Kotlo K.U., Hesabi B., Danziger R.S. Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2011, 301:C929-C937.
28. Kukovetz W.R., Holzmann S., Wurm A., Poch G. Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 1979, 310:129-138.
29. Larsson L.I., Maus T.L., Brubaker R.F., Nathanson J.A. Topically applied hydralazine: effects on systemic cardiovascular parameters, blood-aqueous barrier, and aqueous humor dynamics in normotensive humans. J.Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 1995, 11:145-156.
30. Lee K.M., Tsai K.Y., Wang N., Ingber D.E. Extracellular matrix and pulmonary hypertension: control of vascular smooth muscle cell contractility. Am. J. Physiol. 1998, 274:H76-H82.
31. Lepple-Wienhues A., Becker M., Stahl F., Berweck S., Hensen J., Noske W., Eichhorn M., Wiederholt M. Endothelin-like immunoreactivity in the aqueous humour and in conditioned medium from cultured ciliary epithelial cells. Curr. Eye Res. 1992, 11:1041-1046.
32. Luna C., Li G., Huang J., Qiu J., Wu J., Yuan F., Epstein D.L., Gonzalez P. Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c. PloS One 2012, 7:e51688.
33. Luscher T.F. Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension?. Am. J. Hypertens. 1990, 3:317-330.
34. Maguire J.J., Davenport A.P. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels invitro. Br. J. Pharmacol. 1995, 115:191-197.
35. Mazzuca M.Q., Khalil R.A. Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem. Pharmacol. 2012, 84:147-162.
36. McKay K.O., Black J.L., Armour C.L. The mechanism of action of endothelin in human lung. Br. J. Pharmacol. 1991, 102:422-428.
37. Meyer D.J., Huxley V.H. Capillary hydraulic conductivity is elevated by cGMP-dependent vasodilators. Circ. Res. 1992, 70:382-391.
38. Millar J.C., Gabelt B.T., Hubbard W.C., Kiland J.A., Kaufman P.L. Endothelin-1 effects on aqueous humor dynamics in monkeys. Acta Ophthalmol. Scand. 1998, 76:663-667.
39. Mooradian D.L., Hutsell T.C., Keefer L.K. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation invitro. J.Cardiovasc. Pharmacol. 1995, 25:674-678.
40. Napoli S.A., Gruetter C.A., Ignarro L.J., Kadowitz P.J. Relaxation of bovine coronary arterial smooth muscle by cyclic GMP, cyclic AMP and analogs. J.Pharmacol. Exp. Ther. 1980, 212:469-473.
41. Nathanson J.A. Nitrovasodilators as a new class of ocular hypotensive agents. J.Pharmacol. Exp. Ther. 1992, 260:956-965.
42. Nathanson J.A., McKee M. Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Investig. Ophthalmol. Vis. Sci. 1995, 36:1765-1773.
43. Noske W., Hensen J., Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefe's Arch. Clin. Exp. Ophthalmol./Albrecht von Graefes Arch. klinis. exp. Ophthalmol 1997, 235:551-552.
44. O'Brien R.F., Robbins R.J., McMurtry I.F. Endothelial cells in culture produce a vasoconstrictor substance. J.Cell. Physiol. 1987, 132:263-270.
45. Ohlstein E.H., Horohonich S., Hay D.W. Cellular mechanisms of endothelin in rabbit aorta. J.Pharmacol. Exp. Ther. 1989, 250:548-555.
46. Okada K., Sugiyama K., Haque M.S., Taniguchi T., Kitazawa Y. The effects of endothelin-1 on intraocular pressure and pupillary diameter in rabbits. Jpn. J. Ophthalmol. 1995, 39:233-241.
47. Pang I.H., Yorio T. Ocular actions of endothelins. Proceedings of the Society for Experimental Biology and Medicine 1997, vol. 215:21-34. Society for Experimental Biology and Medicine.
48. Paolocci N., Ekelund U.E., Isoda T., Ozaki M., Vandegaer K., Georgakopoulos D., Harrison R.W., Kass D.A., Hare J.M. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H1982-H1988.
49. Perez Vallina J.R., Menendez Antolin L., Cantabrana B., Sanchez M., Hidalgo A. Nitric oxide and cyclic nucleotides participate in the relaxation of diclofenac on rat uterine smooth muscle. Gen. Pharmacol. 1998, 30:25-29.
50. Prasanna G., Dibas A., Tao W., White K., Yorio T. Regulation of endothelin-1 in human non-pigmented ciliary epithelial cells by tumor necrosis factor-alpha. Exp. Eye Res. 1998, 66:9-18.
51. Prasanna G., Hulet C., Desai D., Krishnamoorthy R.R., Narayan S., Brun A.M., Suburo A.M., Yorio T. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol. Res. Off. J. Ital. Pharmacol. Soc. 2005, 51:41-50.
52. Qi H., Zheng X., Qin X., Dou D., Xu H., Raj J.U., Gao Y. Protein kinase G regulates the basal tension and plays a major role in nitrovasodilator-induced relaxation of porcine coronary veins. Br. J. Pharmacol. 2007, 152:1060-1069.
53. Quigley H.A. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 1996, 80:389-393.
54. Renieri G., Choritz L., Rosenthal R., Meissner S., Pfeiffer N., Thieme H. Effects of endothelin-1 on calcium-independent contraction of bovine trabecular meshwork. Graefe's Arch. Clin. Exp. Ophthalmol./Albrecht von Graefes Arch. klinis. exp. Ophthalmol. 2008, 246:1107-1115.
55. Ridnour L.A., Thomas D.D., Donzelli S., Espey M.G., Roberts D.D., Wink D.A., Isenberg J.S. The biphasic nature of nitric oxide responses in tumor biology. Antioxid. Redox Signal. 2006, 8:1329-1337.
56. Rosenthal R., Choritz L., Zorn R., Munzer G., Fromm M., Pfeiffer N., Thieme H. Endothelin receptor B in trabecular meshwork. Exp. Eye Res. 2007, 85:482-491.
57. Schneemann A., Dijkstra B.G., van den Berg T.J., Kamphuis W., Hoyng P.F. Nitric oxide/guanylate cyclase pathways and flow in anterior segment perfusion. Graefe's Arch. Clin. Exp. Ophthalmol./Albrecht von Graefes Arch. klinis. exp. Ophthalmol 2002, 240:936-941.
58. Schrammel A., Behrends S., Schmidt K., Koesling D., Mayer B. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 1996, 50:1-5.
59. Seltzer J.L., Lee A.Y., Akers K.T., Sudbeck B., Southon E.A., Wayner E.A., Eisen A.Z. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp. Cell Res. 1994, 213:365-374.
60. Stamer W.D., Lei Y., Boussommier-Calleja A., Overby D.R., Ethier C.R. eNOS, a pressure-dependent regulator of intraocular pressure. Investig. Ophthalmol. Vis. Sci. 2011, 52:9438-9444.
61. Stamer W.D., Seftor R.E., Williams S.K., Samaha H.A., Snyder R.W. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr. Eye Res. 1995, 14:611-617.
62. Stumpff F., Strauss O., Boxberger M., Wiederholt M. Characterization of maxi-K-channels in bovine trabecular meshwork and their activation by cyclic guanosine monophosphate. Investig. Ophthalmol. Vis. Sci. 1997, 38:1883-1892.
63. Sumner M.J., Cannon T.R., Mundin J.W., White D.G., Watts I.S. Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol. 1992, 107:858-860.
64. Taniguchi T., Haque M.S., Sugiyama K., Okada K., Nakai Y., Kitazawa Y. Effects of endothelin A and B receptors on aqueous humor dynamics in the rabbit eye. J.Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 1996, 12:123-130.
65. Taniguchi T., Okada K., Haque M.S., Sugiyama K., Kitazawa Y. Effects of endothelin-1 on intraocular pressure and aqueous humor dynamics in the rabbit eye. Curr. Eye Res. 1994, 13:461-464.
66. Tao W., Prasanna G., Dimitrijevich S., Yorio T. Endothelin receptor A is expressed and mediates the [Ca2+]i mobilization of cells in human ciliary smooth muscle, ciliary nonpigmented epithelium, and trabecular meshwork. Curr. Eye Res. 1998, 17:31-38.
67. Underwood J.L., Murphy C.G., Chen J., Franse-Carman L., Wood I., Epstein D.L., Alvarado J.A. Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am. J. Physiol. 1999, 277:C330-C342.
68. Vesey C.J., Sweeney B., Cole P.V. Decay of nitroprusside. II: Invivo. Br. J. Anaesth. 1990, 64:704-709.
69. Wang R.F., Podos S.M., Serle J.B., Baltatu O.C. Effect of SPP 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes. Curr. Eye Res. 2011, 36:41-46.
70. Wanstall J.C., Homer K.L., Doggrell S.A. Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Curr. Vasc. Pharmacol. 2005, 3:41-53.
71. Wiederholt M., Schafer R., Wagner U., Lepple-Wienhues A. Contractile response of the isolated trabecular meshwork and ciliary muscle to cholinergic and adrenergic agents. Ger. J. Ophthalmol. 1996, 5:146-153.
72. Wiederholt M., Sturm A., Lepple-Wienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Investig. Ophthalmol. Vis. Sci. 1994, 35:2515-2520.
73. Wiederholt M., Thieme H., Stumpff F. The regulation of trabecular meshwork and ciliary muscle contractility. Prog. Retin. Eye Res. 2000, 19:271-295.
74. Wollensak G., Schaefer H.E., Ihling C. An immunohistochemical study of endothelin-1 in the human eye. Curr. Eye Res. 1998, 17:541-545.
75. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. Anovel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
76. Ziegler T., Silacci P., Harrison V.J., Hayoz D. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 1998, 32:351-355.